SynthesisSensors (Basel, Switzerland)2025
A Systematic Review of Surface Electromyography in Sarcopenia: Muscles Involved, Signal Processing Techniques, Significant Features, and Artificial Intelligence Approaches.
Synthesis in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Optimization and Device-Level Validation of the i-Phagia Surface Electromyography Submental Sensor Patch for Swallowing Monitoring: A Randomized Crossover Design Study.Journal of speech, language, and hearing research : JSLHR · 2026Trial
- Trial
- An Intelligent Wearable EMG Sensing Framework for Athlete Neuromuscular Monitoring and Performance Progression Assessment.Biosensors · 2026Article
- Development and Clinical Application of Digital Biomarkers for Sarcopenia.Journal of bone metabolism · 2026Review
- Assessment of surface EMG biomarkers in sarcopenic motor dysfunction during postural stabilization.GeroScience · 2026Article
- Wearable Hybrid Strain-Myoelectric Sensing System for Machine-Learning-Assisted Sarcopenia Screening.Small science · 2026Article
- What causes loss of muscle mass in primary sarcopenia: A MUNIX analysis and correlation with plasma biomarkers.Acta neurologica Belgica · 2026Article
- Neuromuscular characteristics of dynamic balance control in patients with sarcopenia: a combined analysis of surface electromyography and limits of stability.Frontiers in aging neuroscience · 2026Article
- Effects of kinesio taping applied over the biceps muscle on muscle activity and muscle fatigue.BMC sports science, medicine & rehabilitation · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia, affecting between 1-29% of the older population, is characterized by an age-related loss of skeletal muscle mass and function. Reduced muscle strength, either in terms of quantity or quality, and poor physical performance are among the criteria used to diagnose it. The current gold standard methods to evaluate sarcopenia are limited in terms of their cost, required expertise, and portability. A possible alternative for sarcopenia detection and monitoring is surface electromyography, which offers comprehensive information on muscle function, but a systematic synthesis of the existing literature is lacking. This systematic review aims to evaluate the application of sEMG in diagnosing and monitoring sarcopenia, focusing on the muscles involved, signal processing techniques, artificial intelligence models, and statistical analysis methods used for data interpretation. Following PRISMA guidelines, a search was performed in PubMed, Scopus, and IEEE databases from 2014 up to December 2024. Original studies using sEMG for sarcopenia diagnosis or assessment in older populations were included. After removing duplicates, 145 articles were identified, of which 18 were included in the final analysis. The findings indicate a growing interest in the adoption of sEMG in sarcopenia assessment. However, methodological heterogeneity among studies limits comparability. sEMG represents a promising option for the early detection of sarcopenia, but standardized guidelines for data collection and interpretation are needed. Future studies should focus on clinical validation and results reproducibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.